SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NYMXF Alzheimer's treatment!
NYMXF 0.1060.0%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Zurowski who wrote (93)3/24/1998 1:28:00 AM
From: Rubber Man   of 132
 
Mr Zurowski:

I've never been too keen on momentum investors pushing their new-found stocks to others so they can get out while leaving others holding the rope, and clearly from the price action from the past few days I can't but help to think you might be one of them. Nevertheless I'll keep my rebuttal to the case in point, unlikely yourself who is fixated by my alias and clearly got a kick out of it.

I have not hid the fact that I'm short. I replied to your original posting to counter some of the points you've made. SI for me, is purely for entertainment purposes; no more, no less.

While I have no doubt Dr Merril is an expert, it is rather coincidental that he is the Editor-in-chief of a new magazine whose exclusive article is based on the same company which he has a financial interest in. I cannot but help think "conflict-of-interest".

Bill Gates is a shrewd business man and very intelligent in his field - his motivations for Microsoft is merely financial (as it should be). This isn't an insult.

Amazing how while I tried to find the magazine that everyone's been talking about, even after repeated requests no one posted a link to it. I was obviously mistaken with the link I posted, but please humor me and answer just when you came upon the link? Usenet have you dated with that link on Mar 19..

I referred to the company as the entity that is gloating - which is exactly what any PR is supposed to do. Investors Relations isn't in the business of humility.

Going public with science, especially speculative science, is unfortunately a side effect of the tabloid age. Society grabs on to headlines and details comes later. "Nymox says finds Alzheimer's cause" is a perfect example.

"science had to be verified" It already has been. I guess the next step is for independent experts to verify this- at least three to six months.

"Also, your comment about scientists being wrong (on occasion) is typically inaccurate: It was an asteroid about 1 kilometer across that made the news last week - not a comet."
You didn't discredit my point that the astronomers were wrong, but the fact that I slipped on the object of interest. I still stand by the statement that scientists, like all humans, have been wrong on occassions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext